+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Brain Disease Modalities & Software Market - Global Forecast 2026-2032- Product Image
Brain Disease Modalities & Software Market - Global Forecast 2026-2032- Product Image
New

Brain Disease Modalities & Software Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 190 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011105
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Brain Disease Modalities & Software Market is entering a crucial phase as next-generation imaging and software platforms transform standards in neurological diagnosis and care. Senior decision-makers in medtech and healthcare must strategically align with technology trends, evolving regulations, and procurement imperatives to remain competitive and compliant.

Market Snapshot: Brain Disease Modalities & Software Market

The Brain Disease Modalities & Software Market advanced from USD 15.28 billion in 2025 to USD 16.27 billion in 2026 and is projected to achieve a compound annual growth rate (CAGR) of 6.93%, anticipating a market value of USD 24.44 billion by 2032. This uptrend underscores momentum in the sector, fueled by innovation in brain imaging platforms, intelligent software, scalable cloud deployments, and a responsive regulatory environment. Technology adoption and market expansion are further propelled by investments in advanced diagnostics and increased focus on outcome-driven neurological care.

Scope & Segmentation: Comprehensive View of Technologies and Stakeholders

  • Imaging Modalities: Includes computed tomography (CT—covering spectral variants), electroencephalography (ambulatory and routine settings), magnetic resonance imaging (structural, functional, and diffusion tensor techniques), magnetoencephalography, positron emission tomography (amyloid and FDG-based), and high-resolution ultrasound (including transcranial Doppler). These technologies are central to evolving clinical workflows and rapid diagnostics.
  • Software Archetypes: Covers artificial intelligence solutions (deep learning, machine learning tools), clinical decision support systems, advanced diagnostic and image analysis platforms, remote monitoring solutions, workflow automation, and telehealth interfaces to support both hospital and decentralized healthcare environments.
  • Disease Indications: Addresses a wide range of neurological disorders, such as Alzheimer's, epilepsy (focal and generalized), multiple sclerosis, Parkinson's disease, various stroke etiologies (ischemic and hemorrhagic), and traumatic brain injuries, reflecting a comprehensive approach across the care continuum.
  • End Users: Incorporates ambulatory surgical centers, neurology and rehabilitation clinics, dedicated diagnostic imaging centers, private and public hospitals, and academic research institutes—each with distinct technology and compliance requirements.
  • Deployment Models: Encompasses cloud-based, hybrid, and on-premise deployment, customized to meet organizational needs for data residency, latency minimization, and regulatory adherence.
  • Distribution Channels: Spans direct sales, strategic distributor collaborations, and digital commerce platforms, ensuring broad access and market reach for providers and end-users.
  • Regional Coverage: The Americas, Europe, Middle East & Africa, and Asia-Pacific, each characterized by unique adoption rates, reimbursement dynamics, and commercialization pathways, highlighting the need for region-specific approaches.

Key Takeaways: Strategic Insights for Decision-Makers

  • AI and machine learning capabilities are now embedded across neuroimaging applications, supporting accelerated diagnoses, routine monitoring, and predictive modeling that align with leading clinical protocols.
  • Cloud-native and hybrid software solutions are increasingly prioritized, enabling organizations to access continuous software enhancements, real-time analytics, and emerging trends such as federated learning, all while meeting evolving data governance needs.
  • Industry progress now relies on cross-disciplinary partnerships, including collaborations among manufacturers, software developers, and academic entities to accelerate validation and meet regulatory demands.
  • The integration of value-based care and payer-driven models drives adoption of outcome-linked analytics and personalized therapy optimization within neurological software and diagnostics.
  • Success in commercialization depends on execution of interoperability standards, robust evidence generation, and effective localization strategies that address regional procurement norms and policy requirements.

Tariff Impact: Navigating Policy and Supply Chain Challenges

  • Tariff adjustments and changing trade policies have increased hardware and software input costs and added pressure to logistics, motivating manufacturers to diversify supplier networks and invest in localized production strategies wherever possible.
  • Procurement strategies are evolving in response, with decision-makers emphasizing flexible service-level agreements and diversified supply sources as safeguards against potential deployment delays or operational disruptions.
  • Restrictions affecting cloud and cross-border data routing are intensifying the requirement for on-premise or regionally-compliant hybrid software deployments, especially in jurisdictions with nuanced data policies.
  • Research and clinical trials may face increased administrative overhead and higher operational costs, which can impact both evidence generation timelines and the pace of market introduction for new solutions.

Methodology & Data Sources

This report integrates insights gathered from primary stakeholder interviews, supplemented by in-depth analysis of secondary literature and recent regulatory documents. Scenario mapping, segment cross-checks, and ongoing validation by clinical advisors ensure accuracy and relevance for industry decision-makers.

Why This Report Matters: Actionable Outcomes for Industry Leaders

  • Enables executives to refine innovation and operational strategies in alignment with rapidly changing clinical standards and procurement practices within the brain disease modalities & software market.
  • Informs teams on product development and evidence generation processes, facilitating partnerships and regional approaches optimized for regulatory transparency and secure supply chains.
  • Provides a segmented, practical perspective to support investment decisions and drive targeted technology adoption across a wide range of end-user settings.

Conclusion

The market is shaped by the integration of advanced imaging, intelligent software solutions, and adaptive supply chain strategies. Decision-makers who focus on evidence-based action and cross-sector collaboration are best positioned to capture lasting value as neurotechnology advances.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Brain Disease Modalities & Software Market, by Software Type
8.1. Ai Based Software
8.1.1. Deep Learning Algorithms
8.1.2. Machine Learning Algorithms
8.2. Clinical Decision Support Software
8.3. Diagnostic Software
8.3.1. Image Analysis Software
8.3.2. Segmentation Software
8.4. Monitoring Software
8.4.1. Neurophysiological Monitoring
8.4.2. Remote Patient Monitoring
8.5. Telehealth Platform
8.6. Workflow Management Software
9. Brain Disease Modalities & Software Market, by Imaging Modality
9.1. Computed Tomography
9.1.1. Conventional Ct
9.1.2. Spectral Ct
9.2. Electroencephalography
9.2.1. Ambulatory Eeg
9.2.2. Routine Eeg
9.3. Magnetic Resonance Imaging
9.3.1. Diffusion Tensor Imaging
9.3.2. Functional Mri
9.3.3. Structural Mri
9.4. Magnetoencephalography
9.4.1. Evoked Response
9.4.2. Resting State
9.5. Positron Emission Tomography
9.5.1. Amyloid Pet
9.5.2. Fdg Pet
9.6. Ultrasound
9.6.1. High Resolution
9.6.2. Transcranial Doppler
10. Brain Disease Modalities & Software Market, by Disease Indication
10.1. Alzheimer's Disease
10.2. Epilepsy
10.2.1. Focal Onset
10.2.2. Generalized Onset
10.3. Multiple Sclerosis
10.4. Parkinson's Disease
10.5. Stroke
10.5.1. Hemorrhagic Stroke
10.5.2. Ischemic Stroke
10.6. Traumatic Brain Injury
10.6.1. Mild Tbi
10.6.2. Severe Tbi
11. Brain Disease Modalities & Software Market, by Deployment Mode
11.1. Cloud Based
11.2. Hybrid
11.3. On Premise
12. Brain Disease Modalities & Software Market, by Distribution Channel
12.1. Direct
12.2. Distributors
12.3. Online Platforms
13. Brain Disease Modalities & Software Market, by End User
13.1. Ambulatory Surgical Centers
13.2. Clinics
13.2.1. Neurology Clinics
13.2.2. Rehabilitation Clinics
13.3. Diagnostic Imaging Centers
13.4. Hospitals
13.4.1. Private Hospitals
13.4.2. Public Hospitals
13.5. Research Institutes
14. Brain Disease Modalities & Software Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Brain Disease Modalities & Software Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Brain Disease Modalities & Software Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Brain Disease Modalities & Software Market
18. China Brain Disease Modalities & Software Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Aspect Imaging Ltd.
19.6. Brainomix Limited
19.7. Canon Medical Systems Corporation
19.8. Carestream Health, Inc.
19.9. Esaote S.p.A.
19.10. Fujifilm Holdings Corporation
19.11. General Electric Company,
19.12. Imaging Biometrics LLC
19.13. International Business Machines Corporation
19.14. IXICO plc.
19.15. Koninklijke Philips N.V.,
19.16. MIM Software, Inc.
19.17. Quantib B.V.
19.18. ScienceSoft USA Corporation
19.19. Siemens Healthineers AG
19.20. VUNO Inc.
List of Figures
FIGURE 1. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEEP LEARNING ALGORITHMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEEP LEARNING ALGORITHMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEEP LEARNING ALGORITHMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICAL DECISION SUPPORT SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICAL DECISION SUPPORT SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICAL DECISION SUPPORT SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SEGMENTATION SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SEGMENTATION SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SEGMENTATION SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEUROPHYSIOLOGICAL MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEUROPHYSIOLOGICAL MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEUROPHYSIOLOGICAL MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REMOTE PATIENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REMOTE PATIENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REMOTE PATIENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TELEHEALTH PLATFORM, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TELEHEALTH PLATFORM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TELEHEALTH PLATFORM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY WORKFLOW MANAGEMENT SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY WORKFLOW MANAGEMENT SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY WORKFLOW MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CONVENTIONAL CT, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CONVENTIONAL CT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CONVENTIONAL CT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SPECTRAL CT, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SPECTRAL CT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SPECTRAL CT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AMBULATORY EEG, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AMBULATORY EEG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AMBULATORY EEG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ROUTINE EEG, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ROUTINE EEG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ROUTINE EEG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIFFUSION TENSOR IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIFFUSION TENSOR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIFFUSION TENSOR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY FUNCTIONAL MRI, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY FUNCTIONAL MRI, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY FUNCTIONAL MRI, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STRUCTURAL MRI, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STRUCTURAL MRI, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STRUCTURAL MRI, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EVOKED RESPONSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EVOKED RESPONSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EVOKED RESPONSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY RESTING STATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY RESTING STATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY RESTING STATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AMYLOID PET, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AMYLOID PET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AMYLOID PET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY FDG PET, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY FDG PET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY FDG PET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HIGH RESOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HIGH RESOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HIGH RESOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRANSCRANIAL DOPPLER, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRANSCRANIAL DOPPLER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRANSCRANIAL DOPPLER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ALZHEIMER'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ALZHEIMER'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY FOCAL ONSET, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY FOCAL ONSET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY FOCAL ONSET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY GENERALIZED ONSET, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY GENERALIZED ONSET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY GENERALIZED ONSET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MULTIPLE SCLEROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PARKINSON'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PARKINSON'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HEMORRHAGIC STROKE, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HEMORRHAGIC STROKE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HEMORRHAGIC STROKE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ISCHEMIC STROKE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ISCHEMIC STROKE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MILD TBI, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MILD TBI, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MILD TBI, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SEVERE TBI, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SEVERE TBI, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SEVERE TBI, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLOUD BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLOUD BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLOUD BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HYBRID, BY REGION, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HYBRID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIRECT, BY REGION, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIRECT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ONLINE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ONLINE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEUROLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEUROLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REHABILITATION CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REHABILITATION CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REHABILITATION CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 197. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 198. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2018-2032 (USD MILLION)
TABLE 199. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2018-2032 (USD MILLION)
TABLE 200. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2018-2032 (USD MILLION)
TABLE 201. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2018-2032 (USD MILLION)
TABLE 202. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 203. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 204. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
TABLE 205. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 206. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
TABLE 207. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 208. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 209. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 210. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 211. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 212. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2032 (USD MILLION)
TABLE 213. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 214. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 215. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 217. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 218. NORTH AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 219. NORTH AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2018-2032 (USD MILLION)
TABLE 220. NORTH AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2018-2032 (USD MILLION)
TABLE 221. NORTH AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2018-2032 (USD MILLION)
TABLE 222. NORTH AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2018-2032 (USD MILLION)
TABLE 223. NORTH AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 224. NORTH AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 225. NORTH AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
TABLE 226. NORTH AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 227. NORTH AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
TABLE 228. NORTH AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 229. NORTH AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 230. NORTH AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 231. NORTH AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 232. NORTH AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 233. NORTH AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2032 (USD MILLION)
TABLE 234. NORTH AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 235. NORTH AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 236. NORTH AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. NORTH AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 238. NORTH AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 239. LATIN AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 240. LATIN AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2018-2032 (USD MILLION)
TABLE 241. LATIN AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2018-2032 (USD MILLION)
TABLE 242. LATIN AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2018-2032 (USD MILLION)
TABLE 243. LATIN AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2018-2032 (USD MILLION)
TABLE 244. LATIN AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 245. LATIN AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 246. LATIN AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
TABLE 247. LATIN AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 248. LATIN AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
TABLE 249. LATIN AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 250. LATIN AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 251. LATIN AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 252. LATIN AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 253. LATIN AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
TABLE 254. LATIN AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2032 (USD MILLION)
TABLE 255. LATIN AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 256. LATIN AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 257. LATIN AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 258. LATIN AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 259. LATIN AMERICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2018-2032 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2018-2032 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2018-2032 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2018-2032 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOM

Companies Mentioned

The key companies profiled in this Brain Disease Modalities & Software market report include:
  • Aspect Imaging Ltd.
  • Brainomix Limited
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • Esaote S.p.A.
  • Fujifilm Holdings Corporation
  • General Electric Company,
  • Imaging Biometrics LLC
  • International Business Machines Corporation
  • IXICO plc.
  • Koninklijke Philips N.V.,
  • MIM Software, Inc.
  • Quantib B.V.
  • ScienceSoft USA Corporation
  • Siemens Healthineers AG
  • VUNO Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 16.27 Billion
Forecasted Market Value ( USD ) by 2032 $ 24.44 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Software Market 2025-2029 - Product Image

Software Market 2025-2029

  • Report
  • 224 Pages
  • Global
From
United States Software Market, By Region, Competition, Forecast and Opportunities, 2020-2030F - Product Image

United States Software Market, By Region, Competition, Forecast and Opportunities, 2020-2030F

  • Report
  • 88 Pages
  • United States
From
Software North America (NAFTA) Industry Guide 2019-2028 - Product Image

Software North America (NAFTA) Industry Guide 2019-2028

  • Report
  • 144 Pages
  • North America
From
Legal AI Software Market Till 2035: Distribution by Type of Component, Type of Deployment, Type of Pricing Model, Type of Technology, Areas of Application, Type of End-Users, Company Size, Type of Business Model, and Key Geographical Regions: Industry Trends and Global Forecasts - Product Image

Legal AI Software Market Till 2035: Distribution by Type of Component, Type of Deployment, Type of Pricing Model, Type of Technology, Areas of Application, Type of End-Users, Company Size, Type of Business Model, and Key Geographical Regions: Industry Trends and Global Forecasts

  • Report
  • 179 Pages
  • Global
From
4D Medical Imaging Software Market - Global Forecast 2025-2030 - Product Image

4D Medical Imaging Software Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.